Page last updated: 2024-10-31

midodrine and Takotsubo Cardiomyopathy

midodrine has been researched along with Takotsubo Cardiomyopathy in 1 studies

Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.

Takotsubo Cardiomyopathy: A transient left ventricular apical dysfunction or ballooning accompanied by electrocardiographic (ECG) T wave inversions. This abnormality is associated with high levels of CATECHOLAMINES, either administered or endogenously secreted from a tumor or during extreme stress.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ramanath, VS1
Andrus, BW1
Szot, CR1
Kaplan, AV1
Robb, JF1

Other Studies

1 other study available for midodrine and Takotsubo Cardiomyopathy

ArticleYear
Takotsubo cardiomyopathy after midodrine therapy.
    Texas Heart Institute journal, 2012, Volume: 39, Issue:1

    Topics: Adrenergic alpha-1 Receptor Agonists; Aged; Female; Humans; Midodrine; Takotsubo Cardiomyopathy; Vas

2012